Future work should include external validation, prospective and interventional studies, and mechanistic investigations (inflammation, redox, lipid pathways, and socioeconomic context) to clarify whether and to what extent modifying anthocyanidin intake can influence CKM–depression outcomes. The gene discussed is CKM; the disease is depressive disorder.